Items where authors include "Shaw, G.C."

Article

Cheng, V.W.T., Vaughn-Beaucaire, P., Shaw, G.C. et al. (31 more authors) (2025) ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity. Cell Reports, 44 (3). 115361. ISSN 2639-1856

Kwan, A., Howard, F. orcid.org/0000-0001-9899-3079, Winder, N. et al. (13 more authors) (2022) Macrophage delivered HSV1716 is active against triple negative breast cancer. Future Pharmacology, 2 (4). pp. 444-459. ISSN 2673-9879

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

Brüning-Richardson, A. orcid.org/0000-0002-9862-9805, Shaw, G.C. orcid.org/0000-0001-9344-4433, Tams, D. et al. (17 more authors) (2022) Correction: Brüning-Richardson et al. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers 2021, 13, 5939. Cancers, 14 (15). 3789. ISSN 2072-6694

Fatania, K. orcid.org/0000-0003-2421-1083, Frood, R. orcid.org/0000-0003-2681-9922, Tyyger, M. et al. (16 more authors) (2022) Exploratory Analysis of Serial 18F-fluciclovine PET-CT and Multiparametric MRI during Chemoradiation for Glioblastoma. Cancers, 14 (14). 3485. ISSN 2072-6694